医学
传统PCI
经皮冠状动脉介入治疗
支架
心肌梗塞
急性冠脉综合征
心脏病学
内科学
血管成形术
血栓形成
介入心脏病学
外科
作者
Hiroyoshi Mori,Michael Joner,Aloke Virmani Finn,Renu Virmani
标识
DOI:10.1093/eurheartj/ehw006
摘要
This editorial refers to ‘Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry’†, by G. Souteyrand et al. on page 1208. Stent thrombosis (ST) is a devastating complication associated with a high morbidity and mortality in patients who have undergone percutaneous coronary intervention (PCI) for coronary heart disease (CHD). In-hospital mortalities of patients suffering from ST have been reported to be as high as 7.9% for acute ST (AST; occurring <24 h after PCI) and subacute ST (SAST; occurring within 30 days after PCI), 3.8% for late ST (LST; occurring within the first year after PCI), and 3.6% for very late ST (VLST; occurring 1 year after PCI).1 Recently, longer duration (30 months) of dual antiplatelet therapy (DAPT) has been shown to reduce, but not eliminate, thrombotic events following drug-eluting stent (DES) implantation as compared with the traditional 12 months of therapy.2 While the introduction of newer generation DES with thinner struts, more biocompatible polymers, and lower drug load have reduced ST rates, it still continues to be a significant cause of morbidity.3 From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) registry of patients undergoing PCI for acute myocardial infarction, the cumulative rates of definite stent thrombosis up to 3 years were 2.0% for bare metal stents (BMS), 2.1% for first-generation DES, and 1.3% for second-generation DES, while cumulative rates of all-cause mortality up to 3 years were 12.8% for BMS, 10.3% for first-generation DES, and 10.6% for second-generation DES.3
科研通智能强力驱动
Strongly Powered by AbleSci AI